Machine Learning

NewBeauty's 16th annual awards spotlight 395 winners, signaling a major shift towards science-backed efficacy and holistic health in the beauty market.

Big Agnes and Hologenix launch a game-changing sleeping bag liner that uses your body heat to boost recovery. Is this the future of backcountry comfort?

A $2.9M investment funds five new projects using DNA and AI to clean up oil sands, secure hydrogen energy, and build a more sustainable future for Alberta.

Nominations are open for the $100,000 Fogarty Prize, continuing the mission of the late Dr. Thomas Fogarty by celebrating life-changing medical innovations.

A new survey reveals bank leaders are worried about AI-driven fraud and competition but lack understanding of advanced AI, creating significant new risks.

With $120M in total funding and a new specialized AI model, depthfirst is betting that domain-specific intelligence is the key to defending code.

Global tech firm HTEC secures SOC 2 Type II status, a critical verification of its security practices that sets a new standard for client confidence.

Apex Systems' top Infor partner award underscores the critical role of enterprise platforms in the AI revolution and its future within the new Everforth brand.

A new report reveals a dangerous paradox: companies are rapidly adopting AI without the security or expertise to manage it, creating a major new threat.

A novel drug aims to break down resistance in hard-to-treat lung and bile duct cancers, with key data set for a major oncology conference.

In a key strategic move, Clear Channel Outdoor partners with Matter Communications to amplify its leadership in an OOH industry transformed by AI and data.

With its new $100M Fund IV, Corazon Capital is doubling down on its operator-led model to back early-stage AI startups focused on amplifying human potential.

A key U.S. patent extends protection for a promising CRPS-1 drug, paving the way for a potential first-in-class treatment for the debilitating condition.

Longhorn Diagnostics unveils LHNVD-501, a novel antibody targeting a universal bacterial component, offering a new front against AMR and chronic inflammation.

A new partnership provides early access to an investigational drug for FAP, offering a potential non-surgical therapeutic option for the first time.

Canadian innovator Stealth Health enters the U.S. with a dual-model telemedicine platform for longevity, targeting both patients and healthcare providers.

Tech veteran Mariana Catz takes the helm at reSolved, as founder Malcolm Klotz shifts to CTO to spearhead AI innovation and global market expansion.

The card-issuing platform's new AI risk score analyzes transactions in milliseconds, aiming to fight advanced fraud while reducing costly false declines.

EV charging firm Hypercharge signals a new era of aggressive expansion, hiring a corporate development expert as its co-founder steps down from the board.

The pharma giant expands its collaboration with OpenProtein.AI, integrating advanced AI to accelerate the creation of new drugs for cancer and autoimmune diseases.